Trial intelligence / Profile preview

ALK HDM Tablet in House Dust Mite Allergic Asthma

NCT00389363Phase 3Completed

Sponsor
ALK-Abelló
Start
Aug 2006
Primary completion
Apr 2008
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of SQ SLIT-tablet in asthma, sponsored by ALK-Abelló. Started Aug 2006; status: completed.

02

Drugs

SQ SLIT-tablet
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00389363.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00389363.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call